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Abstract
Introduction. Oral anticoagulant therapy is commonly used to prevent deep vein thrombosis (DVT). However, it might increase the risk of intraoperative and
postoperative bleeding. Graduated compression stockings (GCS) reduced DVT risk, but there is a lack of supporting evidence. Thus, the study aimed to find the efficacy
of GCS compared to the pharmacological method in high-risk surgical patients.
Method. Literature search proceeded in Cochrane, ClinicalKey, and PubMed. Using keywords graduated compression stockings" or "mechanic" or mechanical") and
("pharmacologic" or "oral anticoagulants" or "NOAC") and "comparison" and "prophylaxis" and ("DVT" or "deep vein thrombosis) and ("surgery" or "surgical").
Results. There were six articles reviewed (27,966 participants). The analysis focused on follow-up, diagnostic method, GCS application days, thromboprophylaxis
baseline used, and outcomes, i.e., DVT and pulmonary embolism. No statistically significant clinical advantage was found in surgical patients using the mechanical
method of GCS for DVT prophylaxis over the pharmacological method.
Conclusion. No significant clinical advantage of using the GCS for DVT prophylaxis over the pharmacological method but preventing intraoperative and postoperative
bleeding. However, the efficacy of GCS remains an issue to be evaluated, as recently supported by insufficient data. However, GCS implementation as a prophylactic
method in surgical patients with a high risk of DVT contraindications for pharmacological prophylaxis is safe.
Keywords: graduated compression stocking, deep vein thrombosis, oral anticoagulants

Introduction
Deep vein thrombosis (DVT) is mainly found in the lower extremities
and pelvic, leading to swelling and painfully affected extremities. If
unmanaged, DVT might lead to a complete resolution of the block or
death due to pulmonary embolism.1 IDENTIA registry data 2020
showed, in Indonesia, that of 360 subjects with acute illness at high risk
of DVT over 40 years, the incidence of DVT was 37.1–40.3%, with a
mean Wells score of 3 and an average of laying down of nine days.1
Meanwhile, NICE data 2010 showed the incidence of DVT in surgical
and nonsurgical patients was 29% and 24%, respectively.2
Some preventive measures have been recommended, both
pharmacological and mechanical. Pharmacologically, oral anticoagulant
administration is the typical treatment applied for prevention purposes.
However, intraoperative and postoperative bleeding in surgical patients
is an adverse effect that should be noted following this treatment.
Mechanical graduated compression stockings (GCS) have reduced the
risk of DVT. Unfortunately, studies focused on this method remain
minimal. Therefore, this study aimed to find the most decisive evidence
showing its efficacy.
Method
A systematic review study was conducted following preferred reporting
items for systematic review and meta-analysis protocols (PRISMA).
The literature search proceeded on Cochrane, PubMed, and ClinicalKey
using keywords "graduated compression stockings" or "mechanic" or
mechanical" and "pharmacologic" or "oral anticoagulants" or "NOAC"

Figure 1. Flow chart in literature search following PRISMA 2020.
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and "comparison" and "prophylaxis" and "DVT" or "deep vein
thrombosis and "surgery" or "surgical". All articles focused on GCS as
the mechanical prevention for DVT compared to pharmacological
measures in high-risk surgical patients. Studies published in English
over the past ten years were included in this study. While the studies
focused solely on (oral anticoagulants), correspondence studies, studies
that did have the outcome, and studies with unavailable full text were
excluded. Selected articles were screened and appraised for the study
design, samples, validation of results, etc., to find the strength of
evidence. The analysis was focused on DVT incidence, diagnostic
method, GCS duration, and follow-up.
Results
In the literature search, 39 articles were found from PubMed. Six articles
were included after the screening, including four randomized controlled
trials and two case-control studies (see figure 1). Of these articles, only
an article definitively compared GCS with pharmacological measures.
Other articles investigated the efficacy of GCS as an adjunct intervention
to pharmacological prophylaxis. These studies were listed in tables 1 and
2, including the level of evidence.
Discussion
Six articles with 27,966 participants from six different centers were
included. Five studies by Chin, Fuji, Nam, Shalhoub, and Suna showed
the incidence of 0.1–0.8%, with p >0.01.3–6 Four articles (Chin, Fuji,
Nam, and Suna) reported the incidence of pulmonary embolism of 0.1–
0.7%, which was not significantly associated with DVT (p >0.01).3–5,7
With this low incidence and limited studies with relatively small
samples, it is difficult to conclude GCS efficacy in preventing DVT in
surgical patients, even though Chin (2010) found that using GCS as
prophylaxis was more effective than those not.3 However, the NICE
guidelines recommend using GCS to prevent DVT in hospitalized
patients who cannot be treated using pharmacological prophylaxis.2
Studies showed that intraoperative and postoperative bleeding is a major
factor in discontinuing pharmacologic prophylaxis in surgical patients at
high risk of DVT. This is in line with the study by Sang et al., 2018, who
showed adverse effects of pharmacological prophylaxis, such as
bruising at the injection site, hematoma, vaginal bleeding, bleeding from
the drain, and hematuria.8 Participants included in this study were
patients who underwent digestive, oncology, gynecology, orthopedic,
and general surgery, thus providing good evidence when applied to this
population. GCS efficacy is evaluated between days seven and fourteen
as reported in four articles (Chin, Fuji, Nam, and Suna).3– 5,7 Sweetland
showed that the risk of developing DVT was within six weeks
postoperatively.9 Thus, the short-term evaluation indicates that these
four articles did not cover a sufficient period of evaluating the risk
manifests and failed to show the prophylactic effect of DVT in surgical
patients. Furthermore, none of the articles agreed on how long GCS to
be applied, both pre– and postoperatively (whether to continue use until
mobilization or until a clinic follow-up visit). This aspect is essential
because DVT and pulmonary embolism can occur after the patient is
discharged or in an outpatient setting.
Most studies carry out duplex ultrasonography (USG) to establish DVT.
This examination is a commonly used method for diagnosing DVT as it
is inexpensive and easy to proceed with. While as a standard diagnostic
method recommended by the 2018 American Heart Association
(AHA), duplex ultrasound is very operator-dependent.10 Although the
basic principle of using Ultrasound is clear, the articles do not explain
the details. It is interesting to note that minimal new studies – particularly
in the last ten years – directly compare mechanical and pharmacological

prophylaxis focused on the outcomes of both DVT and pulmonary
embolism.11–17
Recommendations and guidelines should be developed to address the
criticism regarding the quality evidence from previous studies, which
was mainly secondary. RCT is the ideal design to find the efficacy of
such an intervention. However, it is realized that RCT is challenging
since treating using a placebo for mechanical prophylaxis is
impossible.17 Therefore, most RCT studies were conducted using
positive clinical trials using accepted general pharmacological
prophylaxis, then adding GCS in the treatment group to assess the
effectiveness of GCS use, resulting in a study of the relative efficacy of
GCS. The challenge is that the data generated by comparing the two
existing prophylactic methods will likely result in a low incidence of
both DVT and pulmonary embolism in both groups, as both
interventions are equally effective. When a study shows no statistically
clear difference, it does not indicate that the role of GCS as a
prophylactic method is not significant, but it is likely that the sample size
used in this study is still too small. The danger is that this can lead to
wrong conclusions and poor clinical decisions.11–17 Another ambiguous
conclusion from studies with control groups receiving pharmacological
prophylaxis is that the prophylactic effect achieved and the degree of
side effects avoided would require a combination of the two if the
desired outcome is achieved. This research method has difficulties,
namely the possibility that the GCS prophylactic method alone does not
affect because the prophylactic effectiveness comes from the baseline
treatment. Therefore, research in this form must be careful in concluding
because it has an ambiguous clinical meaning.11Patients who do not
receive a GCS may quickly realize they are not receiving active
therapy.11–17
Another challenge was standardizing the application because the
technique is not pressure-controlled by design but operator-dependent.
Also, the material used and the anatomy of the patient's foot are
immensely varied. Another critical issue is rationalizing the expected
primary effect, which is to prevent thrombus formation in deep veins.
Finding objective measures in the assessment is not easy since many
factors play a role in venous flow.11–17 It is necessary to conduct trials to
evaluate the efficacy with a more significant effect size. Along with the
development of science and technology, there are possibilities to
proceed with future studies focused on comparing GCS with oral
anticoagulants for prophylaxis purposes. In addition, the ideal
compression with individual adjustment to the change in deep venous
blood flow can be objectively evaluated to obtain the best mechanical
effect.11–17
The review failed to find the research questions due to insufficient data;
studies focused on mechanical and pharmacological prophylaxis,
referred to as minimal. These studies used thromboprophylaxis as the
baseline, which may lead to bias in evaluating GCS efficacy. Further,
the application of GCS in these studies considerably varied between 714 days to six weeks postoperatively, unable to demonstrate the true
magnitude of the prophylactic effect of DVT in surgical patients as DVT
and pulmonary embolization may occur after hospital discharge.
Conclusions
No significant clinical advantage of using the GCS for DVT prophylaxis
over the pharmacological method but preventing intraoperative and
postoperative bleeding. However, the efficacy of GCS remains an issue
to be evaluated, as recently supported by insufficient data. However,
GCS implementation as a prophylactic method in surgical patients with
a high-risk of DVT who have contraindications for pharmacological
prophylaxis is safe.
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Table 1. Study characteristics (part A)
Author, Year

Country

Study Design

Total
participants

Age
(mean ± SD)

Gender

Diagnostic
Method of DVT

Follow-up period
(days/month)

Statistical Analysis

Level of
evidence*

Chin, 20103

Singapore

Multicentered
RCT

440

65 ± 22

Male
and female

USG duplex

One month

Chi-square test

2

Chi-square test

2

Chi-square test

4

Chi-square test,
T-test,
Fisher exact test

2

T-test,
Fisher exact test

4

Generalized linear
modeling, noninferiority

2

1.

Control group with
edoxaban: 70.9 ±7.9
2. Control group with
Multicentered
enoxaparin: 71.7 ±7.8
Male and
Fuji, 20164
Japan
201
Venography
25 - 35 days
RCT
3. Treatment group with
female
edoxaban: 73.5 ±6.1
4. Treatment group with
enoxaparin: 73.2 ±7.0
1. Control group: 82.2 ± 6.3
Male and
Nam, 20175
South Korea
Case-control
539
CT angiography
One month
2. Treatment group: 82.0 ± 5.6
female
1. Group A: 54.2 ± 9.4
Multicentered
2. Group B: 54.7 ± 11
Sang, 20188
China
625
Female
USG duplex
Six months
RCT
3. Group C: 52.6 ± 9.9
4. Group D: 53.5 ± 10.5
1. Control group:
Perioperative during
2. 61.8 ± 18.7
Male and
Suna, 20207
German
Case-control
24,273
USG duplex
January 20063. Treatment group: 61.6 ±
female
January 2011
18.4
1. Control group:
Multicentered
59.3 ± 15.2
Male and
14-21, and 90
Shalhoub,
England
1,888
USG duplex
RCT
2. Treatment group:
female
postoperative days
58.1 ± 14.9
*levels of evidence according to Center of Evidence-Based Medicine University of Oxford 2011, CT: Computed Tomography, RCT: Randomized Controlled Trial, USG: Ultrasonography
Table 2. Study characteristics (part B)
Author,
Inclusion Criteria
Exclusion Criteria
Year
Patients
undergoing
History of using
elective surgery
anticoagulant/aspirin,
Chin,
for total knee
previous PE and DVT,
20103
arthroplasty
bleeding,
without a
stroke within three months,
predisposition to
allergy to heparin
VTE

Fuji,
20164

Not mentioned

Patients who have
used IPC

Disciplines

Orthopedic
surgery

Orthopedic
surgery

Control

110

100

Treatment

110

101

GCS Application
(days)

5-7 days

11-14 days

Baseline
Thromboprophylaxis

Not given

Edoxaban or
enoxaparin

DVT

Outcomes
PE

Prevalence:
Control group 22% vs GCS
13%, p = 0.119
Control group 22% IPC
8%, p = 0.032
Control group 22%

1% vs. 1%
p = 0.571

Asymptomatic:
Control group with
edoxaban 3/52 (5.8%)
Control group with
enoxaparin 10/48 (20.8%)
Treatment group with
edoxaban 2/53 (3.8%)
Treatment group with
enoxaparin 4/48 (8.4%)

No patient had PE

Others
Participants were
divided
into four groups:
1. Without
prophylaxis,
1. GCS only
2. IPC only
3. LMWH only

No data
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Table 2. Study characteristics (part B) cont.
Author,
Inclusion
Exclusion Criteria
Year
Criteria
Patients >70
years of age
undergoing
History of laying down
Nam,
surgery for
before the injury
5
2017
control
Previous VTE,
fracture of the
Using warfarin
femoral neck or
intertrochanteric
fracture

Sang,
20188

Suna,
20207

Shalhoub
20206

Age > 18 years,
have
postoperative
risk factors for
VTE willing to
sign the
informed
consent form

Using VTE
prophylaxis
before the study

Disciplines

Orthopedic
(hip fracture
surgery)

gynecology
surgery

Control

404

0

Surgical
patients
between
January 2006
January 2011

Age <18 years
Has contraindications
for GCS: PAD, PAOD.

General and
orthopedic
surgery

12612

Inpatient
elective surgery
patients with
moderate to high
risk of VTE, able
to give informed
consent to
participate in the
study, over 18
years of age

Contraindicated to
LMWH, GCS (PAD,
stroke, individuals
undergoing lower limb
surgery),
thrombophilia, previous
VTE, pregnancy

General
surgery
(Upper and
lower
gastrointestina
l tract)

948

Treatment

135

Group
A: 159
Group
B:157
Group
C: 153
Group
D: 156

GCS Application
(days)

Starting 18
months before
surgery

Since arriving
in the
operating
room or 2
hours
postoperatively
Furthermore,
it is used for
16 hours every
day to 7
postoperative
days

Baseline
Thromboprophylaxis

Outcomes

Aspirin, clopidogrel,
LMWH

Symptomatic:
Control group 30/404
(7.4%) vs treatment group
3/135 (2.2%) with
OR 0.28 (95% CI)
p = 0.042

Patients were divided
into four groups:
A. GCS only
B. GCS + LMWH
C. GCS+IPC
D. GCS+IPC+LMWH

Of the 625 patients, 32 had
DVT:
Group A: 14 (8.8%),
Group B: 6 (3.8%),
Group C: 8 (5.2%),
Group D: 4 (2.6%).
Overall incidence
(32/625)
5.1%

11661

During the
perioperative
period

LMWH

940

During
hospitalization
up to 90 days
postoperatively

LMWH

Symptomatic:
control group 17 (0.1%)
vs treatment group 22
(0.19%)
RR 0.715
p >0.05 95%CI
(0.380-1.345)
Symptomatic:
Control group 0.2% vs
treatment group 0.1%
Asymptomatic:
Control group 1.5% vs
treatment group 1.4%
VTE:
Control group 16/937 (1.7%)
vs treatment group 13/921
(1.4%) (risk difference
0.30% with 95%CI 0.65%–
1.26% p <0.01 for noninferiority

Control group
15/404 (3.7%) vs
Treatment group
2/135 (1.5%) with
OR 0.39 (95% CI)
p = 0.223

Of the 625patients, 12
with PE:
Group A: 7 (4.4%),
Group B: 1 (0.64%),
Group C: 3 (1.96%),
Group D: 1 (0.64%).
Overall incidence
(12/625) 1.9%

No data

Observation
on 7th postop days, no
major bleeding and
heparin-induced
thrombocytopenia
Group A no bleeding.
Group B 13/28 with
bruising at the
injection site, 6//28
with hematoma, and
5/28 with vaginal
bleeding.

Symptomatic:
Control group 19(0.2%)
vs treatment group 29
(0.2%) with RR 0.795
p >0.05 (95%CI 0.6321.000)

Control group 2/937
(0.2%)
vs treatment group
1/921 (0.1%)

No data

CT: Computed Tomography, DVT: Deep Vein Thrombosis, PE: Pulmonary Emboli, GI: Gastrointestinal, IPC: Intermittent Pneumatic Compression, LMWH: Low Molecular Weight Heparin, PAD: Peripheral Arterial Disease, PAOD:
Peripheral Arterial Occlusive Disease, RCT: Randomized Controlled Trial, USG: Ultrasonography
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